Advanced Malignant Neoplasm research hub

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

This study is testing a new drug called ziftomenib for people with a type of blood cancer called acute myeloid leukaemia (AML) that has come back or not responded to previous treatments. It's the first time this drug is being used in people.